Related Experiment Video
Updated: Apr 8, 2026
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.8K
Targeting melanoma with NT157 by blocking Stat3 and IGF1R signaling
E Flashner-Abramson1, S Klein1, G Mullin1
1Department of Biological Chemistry, Unit of Cellular Signaling, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
Oncogene
|June 30, 2015
Summary
The novel compound NT157 targets two key cancer pathways, IGF1R-IRS1/2 and Stat3 signaling. This dual-targeting approach shows significant anti-cancer effects in melanoma models.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Cancer drug resistance is a major challenge, often stemming from tumor heterogeneity and genomic instability.
- Targeting single signal transduction pathways frequently proves insufficient for effective cancer treatment.
Purpose of the Study:
- To investigate the novel compound NT157 as a dual-targeting anti-cancer agent.
- To elucidate the specific signal transduction pathways inhibited by NT157.
Main Methods:
- Preclinical evaluation of NT157 in A375 human melanoma cells.
- Assessment of NT157 efficacy in a murine model of metastatic melanoma.
Main Results:
- NT157 was confirmed to target the Insulin-like Growth Factor 1 Receptor (IGF1R)-Insulin Receptor Substrate (IRS1/2) pathway.
- NT157 also effectively inhibits the Signal Transducer and Activator of Transcription 3 (Stat3) signaling pathway.
- Demonstrated significant anti-cancer activity in both cell lines and animal models.
Conclusions:
- NT157 exhibits dual-targeting capabilities against critical cancer pathways.
- This dual-inhibition strategy holds promise for overcoming drug resistance and treating advanced melanoma.
Related Concept Videos
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
01:27Tumor Immunotherapy
2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K